Cardiopulmonary Bypass Surgery
8
0
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
83.3%
-3.2% vs benchmark
25%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Prediction of Acute Kidney Injury After Cardiac Surgery With Cardiopulmonary Bypass
Assement of Left Ventricular Function Before Decannulation in Cardiac Surgery :Visual Estimation vs TEE
Methylene Blue-Enhanced Ultrafiltration Improves Outcomes After Cardiopulmonary Bypass
HPI (Hypotension Prediction Index) Care Trial
Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial
Efficacy of Pathogen Inactivation Strategies for Platelet Transfusion
CARINAE for Stress Relief in Perioperative Care
Haemostatic Markers in Cardiopulmonary Bypass